Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Cancer vaccine - Acuvax

Drug Profile

Cancer vaccine - Acuvax

Alternative Names: p53 cancer vaccine - Avantogen; Pentrix; Pentrys; Pentrys prostate vaccine - Avantogen; Prostate cancer vaccine - Avantogen

Latest Information Update: 02 Sep 2015

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Avantogen
  • Developer Acuvax
  • Class Cancer vaccines
  • Mechanism of Action Immunostimulants; Tumour suppressor protein p53 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Prostate cancer

Most Recent Events

  • 28 Apr 2006 This vaccine is still in active development
  • 30 May 2005 Australian Cancer Technology is now called Avantogen
  • 23 Mar 2005 Australian Cancer Technology has completed enrolment in a phase IIb trial for hormone-refractory prostate cancer in Australia
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top